Your browser doesn't support javascript.
loading
PRSS1 Upregulation Predicts Platinum Resistance in Ovarian Cancer Patients.
Xing, Linan; Tian, Songyu; Mi, Wanqi; Zhang, Yongjian; Zhang, Yunyan; Zhang, Yuxi; Xu, Fengye; Zhang, Chunlong; Lou, Ge.
Affiliation
  • Xing L; Department of Gynecology, Harbin Medical University Cancer Hospital, Harbin, China.
  • Tian S; Department of Gynecology, Harbin Medical University Cancer Hospital, Harbin, China.
  • Mi W; College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China.
  • Zhang Y; Department of Gynecology, Harbin Medical University Cancer Hospital, Harbin, China.
  • Zhang Y; Department of Gynecology, Harbin Medical University Cancer Hospital, Harbin, China.
  • Zhang Y; College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China.
  • Xu F; College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China.
  • Zhang C; College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China.
  • Lou G; Department of Gynecology, Harbin Medical University Cancer Hospital, Harbin, China.
Front Cell Dev Biol ; 8: 618341, 2020.
Article in En | MEDLINE | ID: mdl-33585454
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: Front Cell Dev Biol Year: 2020 Document type: Article Affiliation country: China Country of publication: Suiza
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: Front Cell Dev Biol Year: 2020 Document type: Article Affiliation country: China Country of publication: Suiza